STOCK TITAN

Ribbon Acquisition (RIBB) DEF 14A Filings

RIBB NASDAQ

Here are the DEF 14A proxy statements from Ribbon Acquisition Corp (RIBB) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow RIBB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RIBB filings page.

Rhea-AI Summary

Ribbon Acquisition Corp. is asking shareholders to approve an amendment to its Trust Agreement so each one‑month SPAC extension requires a deposit into the trust of the lesser of $50,000 or $0.033 per then‑outstanding public share, instead of the previously disclosed $125,000 per month from the sponsor.

As of February 20, 2026, the trust held about $37,385,608.09 for 3,563,133 public shares, implying an estimated redemption price of roughly $10.49 per share. Shareholders can redeem regardless of how they vote, and a separate proposal would allow adjournment if support for the trust amendment is initially insufficient. The board recommends voting in favor, noting a pending business combination with DRC Medicine Ltd. that may require additional time to close.

Rhea-AI Summary

Ribbon Acquisition Corp. is asking shareholders to approve several changes that would extend the deadline to complete a business combination from January 16, 2026 to January 16, 2027. If the extension is approved, the sponsor is expected to make fixed monthly contributions of $125,000 into the trust account as non-interest-bearing loans, repayable only if a deal closes. The trust held about $51,792,864.57 as of December 15, 2025, or an estimated $10.4069 per public share for redemption, and this could rise to about $10.59 with all assumed sponsor contributions and no additional redemptions. Shareholders may redeem regardless of how they vote, and if the extension and related proposals fail and no deal is completed by January 16, 2026, the company will redeem all public shares and liquidate.